T2 Biosystems EBIT per Share
The EBIT per Share of T2 Biosystems (TTOO) as of Oct 15, 2026 is -11.02 USD. In the previous year, EBIT per Share was -7.25 USD — a change of 52.09% (lower).
Get this data via API
Financial Data API
EBIT per Share
-11.02USD
YoY
52.09%
Last updated:
The T2 Biosystems EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 0.00USD | -100.00% |
| est | -3.34USD | -37.26% |
| est | -5.33USD | -489.06% |
| est | 1.37USD | +8.12% |
| est | 1.27USD | +13.88% |
| est | 1.11USD | +39.53% |
| est | 0.80USD | -107.66% |
| est | -10.41USD | -5.60% |
| -11.02USD | +52.09% | |
| -7.25USD | -94.48% | |
| -131.36USD | -5.84% | |
| -139.51USD | -63.12% | |
| -378.30USD | +651.06% | |
| -50.37USD | -32.42% | |
| -74.53USD | -55.23% | |
| -166.47USD | -18.19% | |
| -203.48USD | +32.91% | |
| -153.10USD | +117.61% | |
| -70.35USD | -32.80% | |
| -104.69USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
T2 Biosystems Stock analysis
Frequently Asked Questions about T2 Biosystems stock
EBIT per Share of T2 Biosystems is -11.02 USD in 2023.
EBIT per Share of T2 Biosystems changed from -7.25 USD to -11.02 USD, representing a 52.09% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share T2 Biosystems since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — T2 Biosystems
All Key Metrics — T2 Biosystems
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth